Navigation Links
Reportlinker Adds World In Vitro Diagnostics Market
Date:4/7/2011

NEW YORK, April 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

World In Vitro Diagnostics Market

http://www.reportlinker.com/p0470752/World-In-Vitro-Diagnostics-Market.html

Global demand to increase 6.1% annually through 2014

The Freedonia Group projects world demand for in vitro diagnostic (IVD) products increasing 6.1 percent annually to nearly $68 billion in 2014. Based on the advanced nature of medical delivery systems and widespread insurance coverage for primary health care procedures, the developed countries combined will absorb more than two-thirds of this total. Demand in the developing countries as a whole will expand faster as medical delivery systems are expanded and upgraded and the availability and accessibility of basic health care services improve.

Nucleic acid testing to be fastest growing type

Clinical chemistry and immunoassay will remain the top two IVD methodologies, the former based on sales of personal blood glucose monitors and test strips and the latter due to the penetration of high value-added chemiluminescent products into infectious disease and drug testing markets. Nucleic acid testing products will post the fastest growth in global demand gains among all IVD products based on throughput, accuracy and speed advantages, especially in the detection of infectious diseases and cancer markers. Because of increasing blood glucose monitoring among diabetic patients, endocrine condition testing will remain the largest IVD application through 2014 and beyond. Due to their ability to quantify heart attack and embolism risk prior to occurrence, hemostasis tests for D-dimer and other cardiac parameters will provide the best growth opportunities among IVD blood testing products. Demand for nucleic acid diagnostics will expand at a strong pace as next- generation PCR (polymerase chain reaction) and microarray technologies penetrate applications involving the analysis and characterization of complex infections and tumors. DNA-based forensic, genetic and identity testing will comprise the fastest growing IVD application through 2014 as the vast potential of law enforcement and genetic screening markets begins to translate into significant revenues. Among other IVD products, cellular analysis and anatomical pathology reagents and instruments will post the best global sales gains. Cellular analysis techniques will continue to dominate cervical cancer testing and penetrate additional cancer diagnostic applications. Anatomical pathology will remain the leading IVD technique for biopsy-based cancer and infectious disease detection.

Most IVD products to benefit from evolving trends

Evolving epidemiological trends and patient care approaches will impact favorably on worldwide growth opportunities for most types of IVD products. The market for clinical chemistry reagents and instruments will benefit from an increasing number of diabetic patients engaging in self-blood glucose monitoring and the expanding use of general health screening in routine patient examinations. The widening availability of chemiluminescent tests with inherent sensitivity and selectivity advantages will broaden applications for immunoassays in therapeutic drug monitoring, drugs of abuse detection and infectious disease testing.

Study coverage

World In Vitro Diagnostics presents historical demand data (1999, 2004 and 2009) plus forecasts for 2014 and 2019 by IVD product (reagents and consumables, instruments and systems), application (e.g., clinical chemistry, immunodiagnostics, nucleic acid testing), world region, and for 32 countries. The study also considers market environment factors, evaluates company market share and profiles 24 US industry competitors, including Abbott Laboratories, Beckman Coulter, Becton Dickinson, Johnson & Johnson, Roche Holding and Siemens Healthcare Diagnostics

TABLE OF CONTENTS

INTRODUCTION xii

I. EXECUTIVE SUMMARY 1

II. MARKET ENVIRONMENT 4

General 4

Economic Factors 6

Recent Economic Trends 6

World Economic Outlook 8

World Demographic Patterns 12

Total Population 13

Population 65 Years & Older 15

World Health Care Trends 16

World Health Expenditures 18

Hospital Beds 22

Physicians 24

Patient Activity 26

Hospital Admissions 27

Surgical Procedures 28

Outpatient Consultations 30

IVD Testing Volume 32

Regulation 34

III. PRODUCT OVERVIEW 37

General 37

Demand by Region 38

Shipments by Region 42

World Trade 44

Demand by Product Group 46

IVD Reagents & Consumables 49

IVD Instruments 51

Clinical Chemistry Products 52

Demand by Region 53

Demand by Product 56

Reagents & Test Kits 57

Standards & Controls 62

Instruments & Systems 64

Demand by Application 64

Producers 65

Immunoassay Products 66

Demand by Region 67

Demand by Product 69

Reagents & Test Kits 70

Instruments & Systems 74

Demand by Application 76

Producers 77

Diabetes Testing 80

Demand by Region 80

Demand by Product 82

Reagents 83

Instruments 86

Producers 88

Blood Testing Products 88

Demand by Region 89

Demand by Product 90

Reagents & Consumables 91

Instruments & Systems 96

Demand by Application 99

Producers 101

Hematology Products 101

Blood Banking Products 103

Hemostasis Products 104

Molecular Diagnostic Products 106

Demand by Region 107

Demand by Product 109

Reagents & Consumables 110

Instruments & Systems 119

Demand by Application 123

Producers 125

Pathology Products 126

Demand by Region 126

Demand by Product 128

Reagents & Consumables 129

Instruments & Systems 130

Demand by Application 131

Producers 132

Cellular Analysis Products 132

Demand by Region 132

Demand by Product 134

Reagents & Consumables 136

Instruments & Systems 138

Demand by Application 142

Producers 142

Microbiology Products 144

Demand by Region 144

Demand by Product 146

Reagents & Consumables 146

Instruments & Systems 148

Demand by Application 149

Producers 151

IV. NORTH AMERICA 152

Market Environment 152

IVD Product Demand 155

United States 156

Canada 162

Mexico 168

V. WESTERN EUROPE 173

Market Environment 173

IVD Product Demand 176

France 178

Germany 183

Italy 188

Spain 194

United Kingdom 199

Other Western Europe 205

VI. ASIA/PACIFIC 212

Market Environment 212

IVD Product Demand 216

Australia 218

China 223

India 228

Japan 235

Other Asia/Pacific 241

VII. OTHER REGIONS 248

Central & South America 248

Brazil 255

Other Central & South America 260

Eastern Europe 267

Russia 273

Other Eastern Europe 277

Africa/Mideast 282

VIII. INDUSTRY STRUCTURE 289

General 289

Market Share 291

Competitive Strategies 297

Mergers & Acquisitions 299

Licensing & Related Agreements 304

Product Development 312

Marketing & Distribution 314

Manufacturing 316

Company Profiles 318

Abbott Laboratories 319

AcroMetrix, see Life Technologies

Affymetrix Incorporated 326

Alere Incorporated 328

ARKRAY Incorporated 333

Bayer AG 337

BBInternational, see Alere

Beckman Coulter Incorporated 340

Becton, Dickinson and Company 350

Biocare Diagnostics Limited 357

Bioline Group, see Meridian Bioscience

bioMerieux SA 358

Bio-Rad Laboratories Incorporated 364

Concateno, see Alere

Danaher Corporation 369

DiaMed, see Bio-Rad Laboratories

DxS, see QIAGEN

Eurogentec, see Kaneka

First Check Diagnostics, see Alere

Gen-Probe Incorporated 372

GTI Diagnostics, see Gen-Probe

Hologic Incorporated 378

Johnson & Johnson 381

Kaneka Corporation 387

Leica Microsystems, see Danaher

Life Technologies Corporation 390

LifeScan, see Johnson & Johnson

Matritech, see Alere

Meridian Bioscience Incorporated 395

MP Biomedicals LLC 399

Olympus Corporation 400

Ortho-Clinical Diagnostics, see Johnson & Johnson

Oxoid, see Thermo Fisher Scientific

Primus, see Trinity Biotech

Prodesse, see Gen-Probe

QIAGEN NV 402

Radiometer Medical ApS, see Danaher

Remel, see Thermo Fisher Scientific

Roche Holding Limited 407

SABiosciences, see QIAGEN

Siemens AG 415

SPD Swiss Precision Diagnostics, see Alere

Sysmex Corporation 423

Tepnel Life Sciences, see Gen-Probe

Thermo Fisher Scientific Incorporated 430

Third Wave Technologies, see Hologic

Trinity Biotech plc 435

Ventana Medical Systems, see Roche Holding

Veridex, see Johnson & Johnson

VircoBA, see Johnson & Johnson

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

Summary Table 3

SECTION II -- MARKET ENVIRONMENT

1 World Macroeconomic Indicators 5

2 World Gross Domestic Product by Region 12

3 World Population by Region 14

4 World Population 65 Years & Older by Region 16

5 World Health Care Indicators 17

6 World Health Expenditures by Region 21

7 World Number of Acute Care Hospital Beds by Region 24

8 World Number of Practicing Physicians by Region 26

9 World Number of Acute Care Hospital Admissions by Region 28

10 World Number of Surgical Procedures by Region 30

11 World Number of Outpatient Consultations by Region 32

12 World Number of IVD Tests by Region 34

SECTION III -- PRODUCT OVERVIEW

1 World In Vitro Diagnostic (IVD) Product Demand by Region 41

2 World IVD Product Shipments by Region 44

3 World IVD Product Net Exports by Region 46

4 World IVD Product Demand by Technology & Type 48

5 World Clinical Chemistry Product Demand by Region 55

6 World Clinical Chemistry Product Demand by Type 56

7 World Clinical Chemistry Product Demand by Application 65

8 World Immunoassay Product Demand by Region 68

9 World Immunoassay Product Demand by Type 69

10 World Immunoassay Product Demand by Application 77

11 World Diabetes Testing Product Demand by Region 82

12 World Diabetes Testing Product Demand by Type 83

13 World Blood Testing Product Demand by Region 90

14 World Blood Testing Product Demand by Type 91

15 World Blood Testing Product Demand by Application 101

16 World Molecular Diagnostic Product Demand by Region 109

17 World Molecular Diagnostic Product Demand by Type 110

18 World Molecular Diagnostic Product Demand by Application 125

19 World Pathology Product Demand by Region 128

20 World Pathology Product Demand by Type 129

21 World Pathology Product Demand by Application 131

22 World Cellular Analysis Product Demand by Region 133

23 World Cellular Analysis Product Demand by Type 136

24 World Cellular Analysis Product Demand by Application 142

25 World Microbiology Product Demand by Region 145

26 World Microbiology Product Demand by Type 146

27 World Microbiology Product Demand by Application 150

SECTION IV -- NORTH AMERICA

1 North America: Health Care Indicators 154

2 North America: IVD Product Demand 156

3 United States: Health Care Indicators 159

4 United States: IVD Product Demand 162

5 Canada: Health Care Indicators 165

6 Canada: IVD Product Demand 167

7 Mexico: Health Care Indicators 170

8 Mexico: IVD Product Demand 172

SECTION V -- WESTERN EUROPE

1 Western Europe: Health Care Indicators 175

2 Western Europe: IVD Product Demand 177

3 France: Health Care Indicators 180

4 France: IVD Product Demand 182

5 Germany: Health Care Indicators 185

6 Germany: IVD Product Demand 187

7 Italy: Health Care Indicators 191

8 Italy: IVD Product Demand 193

9 Spain: Health Care Indicators 196

10 Spain: IVD Product Demand 198

11 United Kingdom: Health Care Indicators 202

12 United Kingdom: IVD Product Demand 204

13 Other Western Europe: Health Care Indicators 208

14 Other Western Europe: IVD Product Demand

by Technology & Type 210

15 Other Western Europe: IVD Product Demand by Country 211

SECTION VI -- ASIA/PACIFIC

1 Asia/Pacific: Health Care Indicators 215

2 Asia/Pacific: IVD Product Demand 217

3 Australia: Health Care Indicators 221

4 Australia: IVD Product Demand 223

5 China: Health Care Indicators 226

6 China: IVD Product Demand 228

7 India: Health Care Indicators 232

8 India: IVD Product Demand 234

9 Japan: Health Care Indicators 238

10 Japan: IVD Product Demand 240

11 Other Asia/Pacific: Health Care Indicators 244

12 Other Asia/Pacific: IVD Product Demand

by Technology & Type 246

13 Other Asia/Pacific: IVD Product Demand by Country 247

SECTION VII -- OTHER REGIONS

1 Central & South America: Health Care Indicators 251

2 Central & South America: IVD Product Demand 254

3 Brazil: Health Care Indicators 258

4 Brazil: IVD Product Demand 260

5 Other Central & South America: Health Care Indicators 264

6 Other Central & South America: IVD Product Demand

by Technology & Type 266

7 Other Central & South America: IVD Product Demand

by Country 267

8 Eastern Europe: Health Care Indicators 270

9 Eastern Europe: IVD Product Demand 272

10 Russia: Health Care Indicators 275

11 Russia: IVD Product Demand 277

12 Other Eastern Europe: Health Care Indicators 279

13 Other Eastern Europe: IVD Product Demand

by Technology & Type 281

14 Other Eastern Europe: IVD Product Demand by Country 282

15 Africa/Mideast: Health Care Indicators 285

16 Africa/Mideast: IVD Product Demand by Technology & Type 287

17 Africa/Mideast: IVD Product Demand by Country 288

SECTION VIII -- INDUSTRY STRUCTURE

1 World IVD Product Sales by Company, 2010 290

2 Selected Acquisitions & Divestitures 301

3 Selected Cooperative Agreements 306

LIST OF CHARTS

SECTION II -- MARKET ENVIRONMENT

1 World Health Expenditures, 2010 22

SECTION III -- PRODUCT OVERVIEW

1 World IVD Product Demand by Region, 2010 42

2 World IVD Product Demand by Technology, 2010 49

SECTION VIII -- INDUSTRY STRUCTURE

1 World IVD Products Market Share by Company, 2010 292

To order this report:

: World In Vitro Diagnostics Market

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Market for Medical Devices, 2nd Edition
2. Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries)
3. Reportlinker Adds Asia Pacific Markets for Dental Bone Graft Substitutes and Other Biomaterials 2011
4. Reportlinker Adds European Markets for Interventional Cardiology Devices 2011 (15 Countries)
5. Reportlinker Adds Global: Pharmaceuticals Industry Guide
6. Reportlinker Adds Asian Vaccine Markets
7. Reportlinker Adds Microscopy Market in Latin America
8. Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
9. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
10. Reportlinker Adds World Anti-Obesity Drug Market 2011-2021
11. Reportlinker Adds World Biological Drugs Market 2011-2021
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)...  Eli Lilly and Company (NYSE: LLY ) today ... disodium) vitamin regimen patent would not presently be infringed by ... , Italy and ... with dextrose solution.  --> ... Appeal held that Lilly,s patent would be indirectly infringed by ...
(Date:2/12/2016)... 12 2016  OMS Supply, a large provider of ... announced today the recent launching of their new company ... of features that enhance the user experience and enable ... --> --> Despite ... company that started in early 2016, they have already ...
(Date:2/12/2016)... LOUISVILLE, Ky. , Feb. 12, 2016 ... it has completed a $47.1 million Series ... investors Cormorant Asset Management, Hillhouse Capital Group ... investors Morningside Venture Investments, AJU IB Investment, ... will be used to further advance clinical ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... 13, 2016 , ... Christie Medical Holdings, Inc. presented the ... VeinViewer® Vision vein finder for the nursing school simulation lab. This ... draw blood, combining technology with traditional technique. , “VeinViewer is a wonderful new ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi , a ... Providers list for its expertise in eClinical Solutions. DDi has built its solution ... technology needs of global clients. DDi provides smarter technology for Clinical Development, Regulatory ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & ... purpose of these scholarships is to encourage applicants to pursue a degree in their ... these two parishes. , “We have available jobs in St. Landry and Evangeline ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , Feb. ... , As Winston Churchill said, “Those who don’t learn from history are doomed to repeat ... when they come knocking this year. But that takes time. , Take a close ...
(Date:2/12/2016)... Angeles, CA (PRWEB) , ... February 12, 2016 , ... ... With a hectic schedule, a demanding job, and no time to decompress, Rabinowitz found ... she dedicated herself to meditation for its impact on her life, implementing a 20-minute-per-day ...
Breaking Medicine News(10 mins):